Benzenesulfonates Concept

Vocabulary Service

MeSH

Overview

subject area of

A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia Journal Articles
A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer Journal Articles
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer Journal Articles
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium Journal Articles
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study Journal Articles
An Exact Control‐Versus‐Treatment Comparison Test Based on Ranked Set Samples Journal Articles
BAY 43-9006: Early Clinical Data in Patients with Advanced Solid Malignancies Journal Articles
Comment on “Mobilization and entry of DNAPL pools into finer sand media by cosolvents: two-dimensional chamber studies” by Michael E. Van Valkenburg and Michael D. Annable Journal Articles
Comparison of Methods for the Purification of Alpha‐1 Acid Glycoprotein from Human Plasma Journal Articles
Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology. Journal Articles
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model Journal Articles
Interleukin 13 and Serotonin: Linking the Immune and Endocrine Systems in Murine Models of Intestinal Inflammation Journal Articles
Intestinal Nematode Infection Ameliorates Experimental Colitis in Mice Journal Articles
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis Journal Articles
Modulatory effects of estrogen in two murine models of experimental colitis Journal Articles
NXY‐059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled, 3‐Period Crossover Phase I Study Journal Articles
Phase I Targeted Combination Trial of Sorafenib and Erlotinib in Patients with Advanced Solid Tumors Journal Articles
Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors Journal Articles
Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma Conferences
Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome? Journal Articles
Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus Journal Articles
Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program Journal Articles
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America Journal Articles
Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors Journal Articles
Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects Conferences
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis Journal Articles
Sorafenib and Radiation Therapy for the Treatment of Advanced Hepatocellular Carcinoma Journal Articles
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium Journal Articles
Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal Inflammation Journal Articles
Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis Journal Articles